Skip to Content

WPI 3171 (Alendronate Sodium 35 mg)

Pill with imprint WPI 3171 is White, Capsule-shape and has been identified as Alendronate Sodium 35 mg. It is supplied by Watson Pharmaceuticals.

Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3171

Alendronate Sodium

Imprint
WPI 3171
Strength
35 mg
Color
White
Size
10.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-3171
Inactive Ingredients
magnesium stearate, mannitol, microcrystalline cellulose, sodium starch glycolate type A potato, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.